Synapse - Find an Expert

33620 Results

People

Ladanyi
Giralt
Motzer
Reuter
Perales
Scher
Zelenetz
Berger
Al-Ahmadie
O'Reilly

Groups

Department of Medicine (15822)
Solid Tumor Oncology Division (9435)
GSK Faculty (7076)
Hematologic Malignancies, Division of (6210)
Center for Hematologic Malignancies (6017)
Survivorship Research (5192)
Department of Pathology and Laboratory Medicine (5172)
Surgery (4871)
Sloan Kettering Institute Faculty (3826)
Sloan Kettering Institute Postdocs (3612)

Results (33620)

On-treatment changes in circulating tumor DNA (ctDNA) level as an early predictor of clinical outcome in the LOTUS randomized phase 2 trial of 1st-line ipatasertib (IPAT) + paclitaxel (PAC) for metastatic triple-negative breast cancer (mTNBC)

Meeting Abstract

Wongchenko, M. J.; Lipson, D.; Clark, T.; Kennedy, M.; Greene, M.; Breese, V.; Tsiros, A.; Kim, S. B.; Saura, C.; Oliveira, M.; more...
Cancer Research (2018)

Fulltext@MSK | Save

Preclinical evaluation of enhanced irofulven antitumor activity in an ERCC3 mutant background by in vitro and in vivo tumor models

Meeting Abstract

Topka, S.; Khalil, S.; De Stanchina, E.; Vijai, J.; Offit, K.
Cancer Research (2018)

Fulltext@MSK | Save

A secondary mutation in BRAF confers resistance to RAF inhibition in a BRAF V600E-mutant brain tumor

Meeting Abstract

Wang, J.; Yao, Z.; Jonsson, P.; Allen, A.; Qin, A. C. R.; Uddin, S.; Dunkel, I. J.; Petriccione, M.; Manova, K.; Haque, S.; more...
Cancer Research (2018)

Fulltext@MSK | Save

Cell-free DNA sequencing in ERBB2-mutant breast cancer patients treated with neratinib and fulvestrant: Exploratory analysis from the phase 2 SUMMIT 'basket' trial

Meeting Abstract

Schram, A. M.; Selcuklu, S. D.; Nagy, R. J.; Smyth, L. M.; Eli, L. D.; Cutler, R. E.; Lalani, A. S.; Hyman, D. M.; Lanman, R. B.
Cancer Research (2018)

Fulltext@MSK | Save

Targeting the IDO and TDO pathway through inhibition of the aryl hydrocarbon receptor

Meeting Abstract

Tchaicha, J.; McGovern, K.; Campesato, L. F.; Coma, S.; Zhang, X. M.; Walsh, M.; Cavanaugh, J.; Merghoub, T.; Wolchok, J.; Manfredi, M.
Cancer Research (2018)

Fulltext@MSK | Save

Genomic characterization of organ-specific metastasis from prospective clinical sequencing of 20,000 cancer patients

Meeting Abstract

Sanchez-Vega, F.; Chatila, W. K.; Ganesh, K.; Penson, A.; Camacho, N.; Jonsson, P.; Reznik, E.; Gao, J. J.; Yaeger, R.; Berger, M. F.; more...
Cancer Research (2018)

Fulltext@MSK | Save

Detecting MSI in plasma: Implications for early detection of lynch associated tumors

Meeting Abstract

Srinivasan, P.; Tran, C.; Reichel, J.; Patel, J. A.; Hasan, M.; Meng, F.; Jing, X.; Middha, S.; Zehir, A.; Yaeger, R. D.; more...
Cancer Research (2018)

Fulltext@MSK | Save

Phosphatidylserine targeting antibody enhances antitumor activity of CAR T cells in mouse melanoma

Meeting Abstract

Schad, S.; Hirschhorn-Cymerman, D.; Budhu, S.; Zhong, H.; Yang, X.; Shan, J.; King, S.; Merghoub, T.; Wolchok, J.
Cancer Research (2018)

Fulltext@MSK | Save

Local drug activation: Making cytotoxics safer for local tumors

Meeting Abstract

Srinivasan, S.; Dela Cruz, F.; Kung, A.; Gaviria, E.; Miller, E.; Yee, N.; Royzen, M.; Mejia-Oneto, J.
Cancer Research (2018)

Fulltext@MSK | Save

The molecular landscape of oncogenic signaling pathways in The Cancer Genome Atlas

Meeting Abstract

Sanchez-Vega, F.; Mina, M.; Armenia, J.; Chatila, W. K.; Luna, A.; La, K.; Dimitriadoy, S.; Liu, D. L.; Kantheti, H. S.; Heins, Z.; more...
Cancer Research (2018)

Fulltext@MSK | Save